Medicare and Erythropoietin
Copyright policy )Medicare and Erythropoietin
Dialysis facilities can make more money from administering epoetin than from dialysis and related routine services, which Medicare has reimbursed at a composite rate since 1983. Dr. Robert Steinbrook writes that in 2007, Congress may consider whether to eliminate financial incentives that may lead to the overuse of epoetin and other separately billable drugs.
Health Services Misuse, Medicare, Recombinant Proteins, United States, Epoetin Alfa, Reimbursement Mechanisms, Hemoglobins, Renal Dialysis, Health Care Reform, Humans, Kidney Failure, Chronic, Health Expenditures, Erythropoietin
Health Services Misuse, Medicare, Recombinant Proteins, United States, Epoetin Alfa, Reimbursement Mechanisms, Hemoglobins, Renal Dialysis, Health Care Reform, Humans, Kidney Failure, Chronic, Health Expenditures, Erythropoietin
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).43 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!